Table 1.
Clinical characteristics of patients.
| Tumor type | TCGA code | Samples with RNA-seq data | Median survival–OS (months) | Events (n) | Median survival time in patients with an OS event | Median survival–RFS (months) | Events (n) | Median survival in patients with a relapse (months) | Sex (F/M) | Stage (S0/S1/S2/S3/S4) | Grade (low/high) | Race (White/Asian/Black-African) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AML | LAML | 151 | 10.13 | 97 | 7.13 | 0.00 | 0 | – | 68/83 | – | – | 135/1/13 |
| Bladder | BLCA | 405 | 17.87 | 179 | 13.60 | 0.00 | 31 | 15.40 | 106/299 | 0/2/130/138/133 | 21/381 | 321/44/23 |
| Breast | BRCA | 1090 | 28.10 | 151 | 42.40 | 21.35 | 84 | 25.77 | 1078/12 | 0/181/619/247/20 | – | 752/61/182 |
| Cervical | CESC | 304 | 21.23 | 71 | 20.23 | 12.75 | 26 | 16.10 | 304/0 | – | 153/119 | 209/20/30 |
| Colon | COAD | 454 | 22.30 | 102 | 13.47 | 0.00 | 23 | 16.87 | 214/240 | 0/75/176/128/64 | – | 212/11/59 |
| Esophagus | ESCA | 161 | 13.57 | 64 | 13.38 | 0.00 | 21 | 7.47 | 23/138 | 0/16/69/49/8 | 82/44 | 100/38/5 |
| Glioblastoma | GBM | 153 | 11.90 | 122 | 12.70 | 0.00 | 1 | 51.67 | 54/99 | – | – | 137/5/10 |
| Glioma | LGG | 510 | 22.12 | 125 | 27.13 | 0.00 | 20 | 19.93 | 228/282 | – | 248/261 | 470/8/21 |
| Head and neck | HNSC | 500 | 21.27 | 217 | 14.33 | 0.00 | 28 | 7.70 | 133/367 | 0/25/70/78/259 | 360/121 | 426/10/47 |
| Kidney (clear cell) | KIRC | 530 | 39.85 | 173 | 27.30 | 0.00 | 15 | 30.00 | 186/344 | 0/265/57/123/82 | 241/281 | 459/8/56 |
| Kidney (papillary) | KIRP | 288 | 25.58 | 44 | 21.37 | 13.22 | 28 | 15.72 | 76/212 | 0/172/21/51/15 | – | 205/6/60 |
| Liver | LIHC | 371 | 19.57 | 130 | 13.85 | 10.73 | 143 | 9.10 | 121/250 | 0/171/86/85/5 | 232/134 | 184/158/17 |
| Lung (adeno) | LUAD | 513 | 21.13 | 187 | 19.93 | 9.80 | 89 | 15.90 | 276/237 | 0/274/121/84/26 | – | 387/7/52 |
| Lung (squamous) | LUSC | 501 | 21.63 | 216 | 17.85 | 11.83 | 61 | 18.40 | 130/371 | 0/244/162/84/7 | – | 349/9/30 |
| Melanoma | SKCM | 468 | 34.45 | 215 | 35.67 | 0.00 | 0 | – | 179/289 | 7/76/140/170/23 | – | 445/12/1 |
| Ovarium | OV | 374 | 34.03 | 230 | 36.55 | 0.00 | 126 | 17.67 | 374/0 | – | 43/321 | 324/11/25 |
| Pancreas | PAAD | 177 | 15.43 | 92 | 12.90 | 0.00 | 23 | 14.97 | 80/97 | 0/21/146/3/4 | 125/50 | 156/11/6 |
| Paraganglioma | PCPG | 178 | 25.08 | 6 | 15.08 | 20.42 | 4 | 27.65 | 101/77 | – | – | 147/6/20 |
| Prostate | PRAD | 495 | 30.80 | 10 | 36.73 | 20.53 | 30 | 25.30 | 0/495 | – | – | 147/2/7 |
| Rectum | READ | 165 | 20.33 | 25 | 20.33 | 0.00 | 6 | 28.68 | 75/90 | 0/30/51/51/24 | – | 80/1/6 |
| Sarcoma | SARC | 259 | 31.57 | 98 | 22.27 | 5.37 | 66 | 11.17 | 141/118 | – | – | 226/6/18 |
| Stomach | STAD | 375 | 14.23 | 147 | 11.60 | 6.60 | 37 | 10.50 | 134/241 | 0/53/111/150/38 | 147/219 | 238/74/11 |
| Testis | TGCT | 134 | 42.03 | 4 | 18.85 | 20.67 | 27 | 15.03 | 0/134 | 0/55/12/14/0 | – | 119/4/6 |
| Thymoma | THYM | 119 | 38.83 | 9 | 28.43 | 0.00 | 0 | – | 57/62 | – | – | 99/12/6 |
| Thyroid | THCA | 502 | 31.47 | 16 | 34.03 | 18.72 | 26 | 16.43 | 367/135 | 0/281/52/112/55 | – | 332/51/27 |
| Uterine | UCEC | 543 | 30.37 | 91 | 23.63 | 21.03 | 57 | 17.33 | 543/0 | – | 218/325 | 372/20/106 |
| ∑ | – | 9720 | 24.33 | 2821 | 19.23 | 23.8 | 972 | 15.6 | 5048/4672 | 7/1941/2023/1567/763 | 1870/2256 | 7031/596/844 |